- Vouliez-vous dire
- intensive case
Résultats de la recherche - 75 results
Botulism: An overlooked cause of bulbar weakness in intensive care: A case report
Publication Type: Peer reviewed scientific article Authors: Adams, Louise; Lamquet, Simon; Julie Linussio; Tom Van Nieuwenhuysen; Alexandra Vodolazkaia; Marina Mukovnikova; Parmentier, Heleen; Herdewyn, Sarah Source: Case Reports in Neurology (2024) Keywo ...
Healthcare-Associated Infections and Antimicrobial Use in Belgian Acute Care Hospitals: Results of the 2022 ECDC Point Prevalence Survey
were receiving at least one antimicrobial, with higher prevalence observed in patients over 65 years (31.1%). Intensive care units (56.3%) and surgical wards (38.7%) demonstrated the highest ...
Antimicrobial Use in Belgian Acute Care Hospitals: Results of the 2022 ECDC Point Prevalence Survey
29.7-32.4%), <65 years : 27.1% (95% CI 25.6-28.6%)). Intensive care units (56.3%), surgical (38.7%), and medical wards (33.1%) demonstrated the highest AU prevalence, while psychiatric wards exhibited the ...
Aetiological and prognostic roles of frailty, multimorbidity and socioeconomic characteristics in the development of SARS-CoV-2 health outcomes: protocol for systematic reviews of population-based studies
infection probability, hospitalisation, intensive care unit (ICU) admission, mechanical ventilation and COVID-19 related mortality among general population and (2) to investigate the prognostic roles of ...
The direct disease burden of COVID-19 in Belgium in 2020 and 2021
model, using Belgian seroprevalence, social contact, hospital, and intensive care admission data, (b) deaths were sourced from the national COVID-19 mortality surveillance, and (c) chronic post-acute ...
Risk Factors Associated with Severe RSV Infection in Infants: What Is the Role of Viral Co-Infections?
pediatric intensive care unit (PICU) admission rates (OR = 5.9, 95% CI = 1.53 to 22.74), longer duration of hospitalization (IRR = 1.25, 95% CI = 1.03 to 1.52), and a higher Bronchiolitis Risk of Admission ...
Homologous versus heterologous prime-boost COVID-19 vaccination: impact on clinical severity of Omicron among hospitalized COVID-19 patients in Belgium
the study population. An adjusted logistic model was build and g-computation was executed to estimate counterfactual risks of different clinical severity outcomes (intensive care unit (ICU) transfer, ...
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
estimate counterfactual risks for severe COVID-19 (combination of severity indicators), intensive care unit (ICU) admission, and in-hospital mortality under exposure to different vaccination schedules. The ...
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
(60-79 years aOR 3.0, 95% CI: 2.4-3.8; 80 years 8.3 (6.6-10.5)) and intensive care unit admission (3.8, 95% CI: 3.4-4.2) increased risk of dying, while early hospital admission after symptom onset ...
Evaluating methodological approaches to assess the severity of infection with SARS-CoV-2 variants: scoping review and applications on Belgian COVID-19 data.
Source: BMC Infect Dis, Volume 22, Issue 1 (2022) Keywords: Belgium COVID-19 Humans intensive care units SARS-CoV-2 Abstract: BACKGROUND: Differences in the genetic material of severe acute respiratory ...